CLASS III Device recall · Reported 25 Mar 2015 · FDA Enforcement Report

N Latex IgM; In-vitro diagnostic reagent recalled

Siemens Healthcare Diagnostics is recalling N Latex IgM; In-vitro diagnostic reagent for the quantitative determination of IgM in, distributed in 7 states. The recall was initiated on 15 Jan 2015 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesCatalog # OQAC11, lots 44018, 44019 and 44042, expiration 4/3/2015
Quantity recalled26

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1289-2015
FDA event ID
70385
Recalling firm
Siemens Healthcare Diagnostics, Newark, DE
Classification
Class III
Status
Terminated
Recall initiated
15 Jan 2015
FDA classified
17 Mar 2015
Reported
25 Mar 2015
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons
Device type
Spinal Implants

Timeline

15 Jan 2015Recall initiated by company
17 Mar 2015Classified by FDA+61 days
25 Mar 2015Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Complaints have been confirmed on failed proficiency testing due to serum samples recovering too low when using some N Latex IgM reagent kit lots 44018, 44019 and 44042.

Product as listed by the FDA

N Latex IgM; In-vitro diagnostic reagent for the quantitative determination of IgM in human cerebrospinal fluid (CSF) and in paired CSF/serum samples by means of particle-enhanced immunonephelometry using the BN II and BN ProSpec Systems. The determination of IgM aids in the evaluation of the patient's immune system.

Where it was distributed

Worldwide Distribution: US distribution in states of: UT , CO, CA , FL , NY , OH , NC and country of : Canada.

CaliforniaColoradoFloridaNorth CarolinaNew YorkOhioUtah

Questions about this recall

Why was it recalled?

Complaints have been confirmed on failed proficiency testing due to serum samples recovering too low when using some N Latex IgM reagent kit lots 44018, 44019 and 44042.

Which lots are affected?

Catalog # OQAC11, lots 44018, 44019 and 44042, expiration 4/3/2015

Where was it sold?

Worldwide Distribution: US distribution in states of: UT , CO, CA , FL , NY , OH , NC and country of : Canada.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Siemens Healthcare Diagnostics

All 694

Other Spinal Implants recalls

All 1,157